期刊文献+

原发性胆汁性肝硬化的细胞免疫学发病机制 被引量:4

Cellular mechanism of immunopathogenesis of primary biliary cirrhosis
下载PDF
导出
摘要 原发性胆汁性肝硬化(PBC)是一种器官特异性的进行性自身免疫疾病,常见于女性,以肝脏门脉周围的淋巴细胞浸润,胆管上皮细胞特异性损伤以及血清中高滴度抗线粒体抗体(AMA)为主要特征。最新的PBC研究采用了CD4启动子控制下的TGFβ受体2显性失活(dnTGFβRⅡ)小鼠模型,这种小鼠模型很好地模拟了PBC患者的典型特征。在这种小鼠的基因背景下,通过分别敲除Rag1,μ以及CD1d基因建立了多种双基因缺陷鼠,通过研究发现T细胞,B细胞以及CD1d限制的NKT细胞等对肝脏淋巴细胞浸润,胆管上皮细胞损伤以及AMA的产生发挥着重要的作用。一系列的细胞免疫学实验结果显示,是CD8+T细胞而非CD4+T细胞在肝脏损伤过程中起着决定性的作用,而B细胞除分泌抗自身抗体之外,还具有抑制PBC发生的免疫调节作用。这些机制的研究为揭示人类PBC疾病的细胞免疫学致病机理提供了有力的证据和依托。 Primary biliary cirrhosis(PBC) is a progressive,organ-specific autoimmune disease that predominantly affects woman and is characterized by lymphocytic infiltration in portal tracts,immune-mediated destruction of small intrahepatic small bile ducts,and the presence of high titers of serum anti-mitochondrial Abs(AMAs).A murine model of PBC,generated by expressing a dominant-negative form of TGFβ receptor type Ⅱ(dnTGFβRⅡ) under the direction of the CD4 promoter,demonstrates several key features of human PBC and has been applied in previous PBC studies.Experimental data from Rag1-/-,μ-/-and CD1d-/-mice on a dnTGFβRⅡ background indicated that T cells,B cells and CD1d-restricted NKT cells plays critical roles in liver injury.Moreover,based on a rigorous series of cellular immunological studies,it is concluded that CD8+,but not CD4+ T cells,play a prominent role in mediating pathogenesis,and that B cells can have a suppressive regulatory effect on the infiammatory response besides just secreting auto-antibodies.These studies provide substantial evidence for a cellular mechanism in human primary biliary cirrhosis pathogenesis
出处 《临床肝胆病杂志》 CAS 2011年第6期584-587,594,共5页 Journal of Clinical Hepatology
关键词 肝硬化 胆汁性 疾病模型 动物 杀伤细胞 天然 B淋巴细胞 T淋巴细胞 liver cirrhosis, biliary disease models, animal killer cells, natural B-lymphocytes T-lymphocytes
  • 相关文献

参考文献21

  • 1Talwalkar JA, Souto E, Jorgensen RA, et al. Natural history of pruritus in primary biliary cirrhosis[J]. Clin Gastroenterol Hepatol, 2003, 1(4): 297-302.
  • 2Kita H, Imawari M, Gershwin ME. Cellular immune response in primary biliary cirrhosis[J], Hepatol Res, 2004, 28(1): 12-17.
  • 3Gershwin ME, Mackay IR. The causes of primary biliary cirrho sis: Convenient and inconvenient truths[J]. Hepatology, 2008, 47(2): 737-745.
  • 4Gershwin ME, Mackay IR, Sturgess A, et al. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis[J]. J Immunol, 1987, 138(10): 3525-3531.
  • 5Shindo M, Mullin GE, Braun-Elwert L, et al. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB)[J]. Clin Exp Immunol, 1996, 105(2): 254-259.
  • 6Yasoshima M, Kono N, Sugawara H, et al. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study[J]. Lab invest, 1998, 78(1): 89-100.
  • 7Van de Water J, Ansari AA, Surh CD, et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis[J]. J Immunol, 1991, 146(1): 89-94.
  • 8Kita H, Matsumura S, He XS, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis[J]. J Clin Invest, 2002, 109(9): 1231-1240.
  • 9Kita H, Naidenko OV, Kronenberg M, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer[J]. Gastroenterology, 2002, 123(4): 1031-1043.
  • 10Moritoki Y, Lian ZX, Wulff H, et al. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers[J]. Hepatology, 2007, 45(2): 314-322.

同被引文献36

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部